Increase transparency and reproducibility of real‐world evidence in rare diseases through disease‐specific Federated Data Networks
Open Access
- 31 March 2024
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 33 (4) , e5778
Abstract
Purpose: In rare diseases, real‐world evidence (RWE) generation is often restricted due to small patient numbers and global geographic distribution. A federated data network (FDN) approach brings together multiple data sources harmonized for collaboration to increase the power of observational research. In this paper, we review how to increase reproducibility and transparency of RWE studies in rare diseases through disease‐specific FDNs.Method: To be successful, a multiple stakeholder scientific FDN collaboration requires a strong governance model in place. In such a model, each database owner remains in full control regarding the use of and access to patient‐level data and is responsible for data privacy, ethical, and legal compliance. Provided that all this is well documented and good database descriptions are in place, such a governance model results in increased transparency, while reproducibility is achieved through data curation and harmonization, and distributed analytical methods.Results: Leveraging the OHDSI community set of methods and tools, two rare disease‐specific FDNs are discussed in more detail. For multiple myeloma, HONEUR—the Haematology Outcomes Network in Europe—has built a strong community among the data partners dedicated to scientific exchange and research. To advance scientific knowledge in pulmonary hypertension (PH) an FDN, called PHederation, was established to form a partnership of research institutions with PH databases coming from diverse origins.Keywords
Funding Information
- Johnson and Johnson
This publication has 9 references indexed in Scilit:
- Implementation of a commercial federated network of electronic health record data to enable sponsor-initiated clinical trials at an academic medical centerInternational Journal of Medical Informatics, 2023
- The Value of Federated Data Networks in Oncology: What Research Questions Do They Answer? Outcomes From a Systematic Literature ReviewValue in Health, 2022
- The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment FrameworkClinical Pharmacology & Therapeutics, 2021
- Combining cox regressions across a heterogeneous distributed research network facing small and zero countsStatistical Methods in Medical Research, 2021
- Federated Networks for Distributed Analysis of Health DataFrontiers in Public Health, 2021
- PS1421 HONEUR (HEAMATOLOGY OUTCOMES NETWORK IN EUROPE) – DISTRIBUTED STATISTICS IN A FEDERATED MODEL TO SUPPORT REAL WORLD DATA RESEARCH IN HEMATOLOGYHemaSphere, 2019
- Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web LayerBioMed Research International, 2017
- Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end usersHuman Mutation, 2012
- A federated architecture for information managementACM Transactions on Information Systems, 1985